SV 1V7 Pill - beige oval, 19mm
Generic Name: fostemsavir
Pill with imprint SV 1V7 is Beige, Oval and has been identified as Rukobia 600 mg. It is supplied by ViiV Healthcare.
Rukobia is used in the treatment of HIV Infection and belongs to the drug class miscellaneous antivirals. Rukobia 600 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SV 1V7
Rukobia
- Generic Name
- fostemsavir
- Imprint
- SV 1V7
- Strength
- 600 mg
- Color
- Beige
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous antivirals
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ViiV Healthcare
- National Drug Code (NDC)
- 49702-0250
See also:
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Atripla
Atripla prevents the human immunodeficiency virus (HIV) from reproducing in your body. Learn about ...
Complera
Complera (emtricitabine, rilpivirine, and tenofovir) is used to treat HIV infection. Includes ...
Stribild
Stribild (cobicistat, elvitegravir, emtricitabine and tenofovir) is used to treat HIV-1 infection ...
Epzicom
Epzicom is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Learn ...
Emtricitabine
Emtricitabine is used for HIV Infection, nonoccupational exposure, occupational exposure
More about Rukobia (fostemsavir)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antivirals
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.